Domestic COS-accredited firms eye European drug market

Published: 2002-04-18 06:59:00

Updated: 2002-04-18 06:59:00

Pharmaceutical industry sources say that there is an increasing trend in the number of accreditation of Certification of Suitability of Monographs of the European Pharmacopoeia (COS), being equal to the certification of US FDA. Thus, it is likely that more brisk export drive of the domestic pharm...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK